United States · Platforms & data · MarketBeat
Zymeworks (NASDAQ:ZYME) Price Target Raised to $39.00

Detailed summary
Citizens Jmp raised their price objective on Zymeworks from $32.00 to $39.00 and gave the stock a "market outperform" rating in a research note on Friday.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)



